Volume 7, Issue 1 (Winter 2021)                   Iran J Neurosurg 2021, 7(1): 15-22 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yousefzadeh-Chabok S, Sharifi G, Ghorbani M, Samadian M, Kalani N, Kazeminezhad A. Comparing Mononostril, Binostril, and One and a Half Nostril Endoscopic Transsphenoidal Approach for Treating Pituitary AdenomaPituitary Adenoma. Iran J Neurosurg 2021; 7 (1) :15-22
URL: http://irjns.org/article-1-248-en.html
1- Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran.
2- Department of Neurosurgery, Skull Base Research Center, School of Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Department of Neurosurgery, Division of Vascular and Endovascular Neurosurgery, School of Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
4- Department of Anesthesiology, Critical Care and Pain Management Research Center, Jahrom University of Medical Sciences, Jahrom, Iran.
5- Department of Neurosurgery, Peymanieh Hospital, Jahrom University of Medical Sciences, Shiraz, Iran. , kazemimd@msn.com
Full Text [PDF 537 kb]   (730 Downloads)     |   Abstract (HTML)  (2675 Views)
Full Text:   (983 Views)
1. Introduction
Bushe and Halves introduced using an endoscope in pituitary operation in 1978. In the mid-1990s, the endoscope was an excellent choice for pituitary surgery with a spacious, bright, and excellent surgical view. A combined approach as an initial endoscopic approach to the sphenoid sinus joined with the standard transsphenoidal microsurgical approach for tumor removal was reported by Yaniv and Rappaport. Later on, Jho and Carrau described the most extensive series of patients with pure Endoscopic Endonasal Transsphenoidal Approach (EETA) [1, 2, 3]. EETA has three types of approaches: Mononostril Endoscopic Transsphenoidal Approach (META), Binostril Endoscopic Transsphenoidal Approach (BETA), and one and a half nostril approach (OETA). It is performed by two techniques: two surgeons (3 or 4 hands) technique and one surgeon (2 hands) technique. 
In BETA, two surgeons work together (3-hand technique): an ENT surgeon and neurosurgeon. First, an ENT (Ear, Nose, Throat) surgeon creates surgical exposure, and then a neurosurgeon starts operation on binostril, with holding the suction in the non-dominant hand and a dissecting instrument in the dominant one as the ENT surgeon holds endoscope in the right nostril. In META, two surgeons work separately (2-hand technique) as the first an ENT surgeon makes exposure, and then a neurosurgeon starts the operation with an endoscope holder (hydraulic or mechanical) [4]. 
The mononostril approach creates less trauma to the nasal mucosa with fewer nasal complications such as crusting, loss of smell, and adhesion, with the main disadvantage as small working room, especially for invasive and extensive macroadenoma. In the one-and-a-half nostril and binostril approach, the integral part for better operative outcomes is the degree of freedom for the senior surgeon, and this occurs with working of the senior surgeon through both nostrils and the assistant surgeon through the right nostril for guiding the endoscope and elimination of the endoscope shaft [5]. From the viewpoint of nasal mucosal incision and removal, the following dissimilarities are present. 
In META, the unilateral posterior nasal mucosa is incised, and the contralateral nasal mucosa is preserved. The main difference between these three approaches is the different ways to remove the nasal septal mucosa. In BETA, the dorsal region of nasal septal mucosa is bilaterally incised and removed, and in OETA, the nasal mucosa is unilaterally incised from sphenoid ostium to mucocutaneous junction of vestibule plus a contralateral mucosal incision. Theoretically, the incidence of nose bleeding and loss of smell are lower in OETA because of the preservation of the contralateral septal olfactory strip and the vascular pedicles. In this paper, we reviewed and compared 3 EETAs (META, OETA, and BETA) and considered the short-term and long-term outcomes, benefits, and complications of these three approaches.

2. Methods and Materials/Patients
To provide up-to-date information on these three approaches, we concisely reviewed these three approaches and their pros and cons. Using the keywords of “neuroendoscopy”, “META”, “OETA”, “BETA”, “pituitary adenoma”, “EETA”, “endoscopy”, “pituitary surgery”, “microscopic transsphenoidal approach”, “binostril endoscopy”, “mononostril endoscopy”, “one and a half nostril endoscopy”, “transcranial approach to pituitary adenoma”, we retrieved all the relevant articles from Google Scholar, PubMed, and Medline. Then, we reviewed them and critically analyzed them.

3. Results
The endoscopic approach can be classified as three approaches: mononostril, binostril, and one and a half nostril. From the technical viewpoint, the mononostril approach is a two-hand technique, and the binostril and one and a half nostril approach can be a three-hand or four-hand technique. Endoscopes create a good and extensive visualization of the surgical field [6, 7]. We compared these three approaches and techniques and consider the short-term and long-term outcomes, benefits, and complications of these three approaches for pituitary adenoma surgery.

4. Discussion
Tumor resection rate

Post-operative MRI can detect tumor resection rate based on the amount of tumor remnant. Based on the tumor resection rate, there is no prominent dissimilarity between META, OETA, and BETA (77.8% in META, 80.3% in BETA, and 79% in OETA) [7, 8, 9, 10, 11]. However, in invasive pituitary macroadenomas (such as tumors with parasellar and suprasellar extension and tumors requiring extended approaches), the preferred approach is the binostril approach because of its better surgical field visualization, maneuverability, and resection rate [12, 13, 14, 15, 16, 17].

Post-operative hormonal recovery rate
For hormone remission rate, there is no prominent dissimilarity between three EETAs (72.9% in META, 77.8% in OETA, and 76% in BETA) [7, 8, 9, 10, 11, 18, 19] and also between the type of hormone-secreting adenoma [7, 8, 9, 10, 11]. The factors against biochemical remission are invasive tumors and previous operations (for microadenomas). 

Post-operative visual recovery
There is no prominent dissimilarity in the META and BETA groups but with a lower rate of improvement in the OETA group without any reasonable and sensible explanation (91.1% in META, 88% in BETA, and 73% in OETA) [7, 8, 9, 10, 11]. For more desirable surgical results and improvement of visual function, it is better to do an operation in the early stage of visual impairment before the occurrence of optic atrophy [20].

Post-operative admission days
There is a prominent dissimilarity between the three EETAs (1.6-6.5 days) [11].

Complications
Neurologic Complications [7, 8, 9, 10, 11].

CSF leakage
No noticeable difference was seen between the three EETAs (2.9% in META, 3.1% in BETA, and 3.5% in OETA).

Diabetes insipidus
The rate of temporary diabetes insipidus is lower in BETA (5.3% in META, 2.9% in BETA, and 5.3% in OETA). But for the permanent diabetes insipidus rate, there is no noticeable difference between META and BETA (1.0% META and 0.9% in BETA) without any information about OETA.

Anterior pituitary dysfunction
The rate of anterior pituitary dysfunction is lower in BETA (6.4% in META, 2.3% in BETA, and 5.3% in OETA).

Meningitis
There is no significant difference between META and BETA (0.8% in META and 0.8% in BETA) without any data in OETA.

Nasal complications
Sinusitis

There is no prominent dissimilarity between META and BETA (0.3% in META and 0.9% in BETA).

Nose bleeding
The rate of nose bleeding is higher in the BETA group than META and OETA (0.4% in META, 1.5% in BETA, and 0% in OETA).

The choice between META, OETA, and BETA
The three most commonly used endoscopic approaches for pituitary adenomas are the META, OETA, and BETA. To evaluate the efficiency of these three approaches, we must consider post-operative results, free and easy movement of surgical instruments, post-operative morbidity, and post-operative quality of life. For general pituitary adenomas, based on the literature review, there are similar results for tumor resection rate, hormonal recovery rate, post-operative visual recovery rate, CSF leak, and occurrence of diabetes insipidus. In invasive pituitary macroadenomas like tumors with parasellar and suprasellar extension and tumors requiring extended approaches, binostril is a better choice. However, the worst outcome of the binostril approach is the damage to the nasal cavity with sinonasal complication, low sinonasal quality of life, and changes in smell sensation. The rate of damage to the nasal cavity is less in META and OETA than in BETA [13, 19, 21]. 
The above items occur for the followings reasons: 1) limitations of meta-analysis, 2) the highly developed endoscopes create a clear extensive view of the operative field and a higher chance of total tumor resection rate so that surgeons can recognize anatomic structures, even in a restricted surgical field, with the usage of different angled endoscopes for the operation of parasellar and suprasellar regions, 3) in the mononostril approach, many surgeons for creation of wide and clear surgical field, separate and move the nasal septum to the contralateral side and some surgeons use a speculum to narrow the surgical passage, and 4) other factors, such as the shared operation with an ENT, the use of intraoperative navigation system or MRI, and the consistency of pituitary adenomas (the majority is soft). 
All the above-mentioned items can increase the good results of the mononostril approach and can cope with most pituitary adenomas. However, we believe that the META limitations are resolved with changes in the lens of the endoscope and some maneuver in creating a visual field in the nasal cavity and transsphenoidal route. In other words, the advantage of the binostril approach is unclear within general pituitary adenomas. In the binostril approach, passing through the middle turbinate can increase the surgical space and clear visualization of anatomic structures in the surgical field, with resultant decrease injury to normal pituitary gland as lower anterior pituitary insufficiency and temporary diabetes insipidus in binostril approach [8, 9, 10, 22, 23, 24, 25, 26].
Comparing traditional microsurgery (microscopic transsphenoidal) with endoscopic endonasal transsphenoidal pituitary surgery and transcranial pituitary surgery
The fundamental reason for pituitary surgery is selecting a surgical approach and technique with maximal safe resection of adenoma and minimal injury to patients. The demerits and merits regarding these three surgical approaches have become a hot topic of discussion. Traditional microsurgery (microscopic transsphenoidal surgery) is similar to endoscopic surgery with two differences. First, it needs Hardy’s speculum, and second, it needs a microscope instead of an endoscope. However, endoscopic endonasal pituitary surgery has a more spacious surgical view, clearer and brighter surgical field anatomy, significantly higher cure rate, less intraoperative and post-operative problems, decreased operative time, less bleeding, elimination of intraoral and transseptal dissection, and decreased admission days [18, 27, 28]. In a retrospective study, all patients underwent microscopic transsphenoidal surgery because of the restriction of endoscopy in the pediatric group and the prevention of extensive anatomical damage. They used submucosal transnasal approach, and most of the tumors were macroadenoma; they could resect the tumor in 90% of patients [29]. In 1% to 4% of pituitary tumors, the transcranial approach is the preferred approach at the following conditions:
1) for removal of an isolated macroadenoma because of a narrow waist at the diaphragma sellae;
2) extension to the cavernous sinus lateral to the carotid artery;
3) anterior extension onto the planum sphenoidale;
4) lateral extension into the middle fossa;
5) fibrous hard pituitary macroadenoma.
For fibrous, hard pituitary macroadenoma, it is better to use the transcranial approach, and tumors with soft consistency are easily resected by suction through the transsphenoidal approach. It is better to do a preoperative assessment of the pituitary macroadenoma tumor consistency and, based on this, detect a suitable type of operative approach, whether transsphenoidal or transcranial approach. The Diffusion-Weighted MR Imaging (DWI) can help predict the detection of the tumor consistency of pituitary macroadenomas. Based on DWI, we can detect an appropriate approach and decreasing the risk of incomplete excision and the chance of recurrence [30, 31, 32]. However, for a more reliable conclusion, further studies are needed [33].

Comparing OETA with BETA
The injury to the nasal cavity is lower in OETA than BETA. The rate of nose bleeding and loss of smell is lower in OETA than BETA for the following reasons. In OETA, on the left side, 2 cm of nasal septal mucosa is excised, and at the right side, a “rescue” flap is created with the preservation of vascular pedicles and olfactory strip. If there is no CSF leakage intraoperatively, the preserved unilateral “rescue” flap is placed back to the normal anatomic position. In BETA, there is a possibility of damage to vascular pedicles and olfactory strips because of bilateral manipulation of posterior septal mucosa. In OETA, recovery of smell post-operatively occurs about three months in 96% of the patients, and sinonasal complications are recovered about six months. The outcome of permanent loss of smell and nose bleeding is better in OETA than in BETA [7].

Comparing OETA with META
Based on the literature review, there is a higher surgical outcome in OETA in comparison to endoscope-based series, and this is because of the broad bright view of the endoscope. In the OETA, we can employ both nasal cavities for using surgical instruments. We have a wide spacious surgical field in comparison to META. So the senior surgeon can freely use surgical instruments for hemostasis, tumor resection, and sellar floor repair and assistant surgeon holding the endoscope. In the META, because of using one side of the nasal cavity, the surgical field is more restricted and limited, and there is a struggle between the endoscope and surgical instruments as in macroadenoma with parasellar extension, and it is better to approach from contralateral nostril about the surgical target area. In OETA, moving the endoscope to the contralateral nostril concerning the surgical target area creates a tremendous surgical field view, spacious wide surgical field, and sufficient space for the free movement of instruments [8, 20, 34, 35, 36, 37].

Comparing BETA with META
In the META, the operation length is shorter than BETA. In META, the maneuverability of surgical instruments like suction cannula, curettes, and endoscope are limited because of restricted passage through a speculum. Speculum prevents injury to the nasal cavity by surgical instruments, but it can cause injury to the nasal mucosa with intranasal bleeding that is more common in META. In BETA, there is no restriction of maneuverability of surgical instruments because of the pliability of nasal structures, and you can dislodge nostrils, turbinates, and the nasal septum by the shaft of rigid instruments, but there is the chance of injury to nasal mucosa or structures. Because of this possibility in BETA, we must do extensive hemostasis and create a broad spacious surgical field with a broader opening of the sphenoid sinus. Briefly, both META and BETA are safe techniques, but in META, because of limited passage, resection of large tumors is difficult. Based on these findings, If there are very large adenomas with extension to parasellar areas or involvement of the cavernous sinus, it is better to use the binostril technique without a speculum. There is no difference between META and BETA in a residual tumor, CSF fistulas, rhinological aspects, and endocrinological or ophthalmological recovery [21].

Usage of the speculum in endoscopic transnasal and microsurgical approach to the sella
Neurosurgeons can use speculum for endoscopic transnasal and microsurgical approach to the sella. A speculum is typically used in META, not in BETA and OETA. In META, the speculum creates a broader surgical passage, and neurosurgeons can easily reach the sphenoid sinus. In META, in comparison to the microsurgical approach, we can pass an endoscope into the sphenoid sinus and sellar space to differentiate tumor tissue from normal hypophysis because of the bright excellent visualization of the surgical field. The speculum limits lighting and lateral visualization and microsurgical approaches; however, this is less relevant in endoscopic approaches. The speculum restricts the bimanual handling of instruments [7, 15, 38, 39, 40].

The advantage of the unilateral “rescue” nasoseptal flap
For rescue flap, a small incision is made at the level of the ostium of the sphenoid sinus and extended anteriorly onto the superior nasal septum. The mucosa is elevated inferiorly from the sphenoid ostium, protecting the posterior septal branch of the sphenopalatine artery for blood supply of rescue flap. Some neurosurgeons create unilateral rescue flap and others bilateral rescue flap. In patients with intraoperative CSF leak reconstruction of the sellar cavity is done using unilateral rescue flap with a successful decrease in the rate of post-operative CSF leak [8, 15, 20, 34, 36, 41]. In the bilateral rescue nasoseptal flap, the chance of injury to nasoseptal mucosa is increased. Based on the literature review, the unilateral rescue flap is efficient in the reconstruction of sellar space, and because of the unilaterality of the flap, the chance of injury to nasal mucosa is decreased with preservation of the contralateral side [18, 42, 43].

5. Conclusion
The demerits and merits regarding the transcranial approach and microscopic transsphenoidal approach and EETA and also between three widely-used EETAs (META, OETA, BETA) have become a hot topic of discussion. Based on the results of this study, the transcranial approach is effective when resection of a pituitary macroadenoma cannot be done with the transsphenoidal route. Microscopic transsphenoidal surgery due to limitation of the endoscopic approach is suitable in pediatric patients and avoided wide anatomical deficit, and for selecting suitable EETA as META, BETA, or OETA, the size and consistency of tumor, general versus invasive pituitary adenoma, and the extent of parasellar and suprasellar extension is essential, but for more reliable conclusion further studies are needed.

Ethical Considerations
Compliance with ethical guidelines

There were no ethical considerations to be considered in this research.

Funding
This research did not receive any grant from funding agencies in the public, commercial, or non-profit sectors. 

Authors' contributions
Conception and design: Shahrokh Yousefzadeh-Chabok, Ali Kazeminezhad; Data analysis and interpretation, drafting the article, critically revising the article, reviewing submitted version of manuscript, approving the final version of the manuscript: All authors. 

Conflict of interest
The authors declared no conflict of interest.

Acknowledgments
We would like to thank the Clinical Research Development Unit of Peymanieh Educational and Research and Therapeutic Center of Jahrom University of Medical Sciences for providing facilities for this work.



References
  1. Bushe KA, Halves E. [Modified technique in transsphenoidal operations of pituitary adenomas (German)]. Acta Neurochirurgica. 1978; 41(1-3):163-75. [DOI:10.1007/BF01809147] [PMID]
  2. Yaniv E, Rappaport ZH. Endoscopic transseptal transsphenoidal surgery for pituitary tumors. Neurosurgery. 1997; 40(5):944-6. [DOI:10.1097/00006123-199705000-00012] [PMID]
  3. Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: Experience with 50 patients. Neurosurgical Focus. 1996; 87(1):44-51. [DOI:10.3171/foc.1996.1.1.4]
  4. Cappabianca P, Cavallo LM, Colao A, Del Basso De Caro M, Esposito F, Cirillo S, et al. Endoscopic endonasal transsphenoidal approach: Outcome analysis of 100 consecutive procedures. Minimally Invasive Neurosurgery: MIN. 2002; 45(4):193-200. [DOI:10.1055/s-2002-36197] [PMID]
  5. Jgannathan J, Laws ER, Jane JJ. Advantages of endoscope and transitioning from microscope to the endoscope for endonasal approaches. In: Kassam AB, Gardner PA, editors. Endoscopic Approaches to Skull Base. Basel: Karger; 2012. pp. 7-21. [DOI:10.1159/000329124]
  6. Mamelak AN, Carmichael J, Bonert VH, Cooper O, Melmed S. Single-surgeon fully endoscopic endonasal transsphenoidal surgery: Outcomes in three-hundred consecutive cases. Pituitary. 2012; 16(3):393-401. [DOI:10.1007/s11102-012-0437-1] [PMID]
  7. Wen G, Tang C, Zhong C, Li J, Cong Z, Zhou Y, et al. One-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas-a technical report. Journal of Otolaryngology - Head & Neck Surgery. 2016; 45(1):60. [DOI:10.1186/s40463-016-0174-y] [PMID] [PMCID]
  8. Dehdashti AR, Garma A, Karabatsou K, Gentili F. Pure endoscopic endonasal approach for pituitary adenomas: Early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery. 2008; 62: 1006-1015. [DOI:10.1227/01.neu.0000325862.83961.12] [PMID]
  9. Zhang YH, Wang ZC, Liu YJ, Zong XY, Song M, Pei A, et al. Endoscopic transsphenoidal treatment of pituitary adenomas. Neurological Research. 2008; 30:581-6. [DOI:10.1179/174313208X298110] [PMID]
  10. Charalampaki P, Reisch R, Ayad A, Conrad J, Welschehold S, Perneczky A, et al. Endoscopic endonasal pituitary surgery: Surgical and outcome analysis of 50 cases. Journal of Clinical Neuroscience. 2007; 14:410-5. [DOI:10.1016/j.jocn.2006.02.014] [PMID]
  11. McLaughlin N, Eisenberg AA, Cohan P, Chaloner CB, Kelly DF. Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery. Journal of Neurosurgery. 2013; 118(3):613-20. [DOI:10.3171/2012.11.JNS112020] [PMID]
  12. Wen G, Tang C, Zhong C, Li X, Li J, Li L, et al. Mononostril versus binostril endoscopic transsphenoidal approach for pituitary adenomas: A systematic review and metaanalysis. PLoS One. 2016; 11(4):e0153397 [DOI:10.1371/journal.pone.0153397] [PMID] [PMCID]
  13. Elhadi AM, Hardesty DA, Zaidi HA, Kalani MYS, Nakaji P, White WL, et al. Evaluation of surgical freedom for microscopic and endoscopic transsphenoidal approaches to the sella. Neurosurgery. 2015; 11(Suppl 2):69-78. [DOI:10.1227/NEU.0000000000000601] [PMID]
  14. Darwish H, El-Hadi U, Haddad G, Najjar M. Management of pituitary adenomas: Mononostril endoscopic transsphenoidal surgery. Basic and Clinical Neuroscience. 2018; 9(2):121-8. [DOI:10.29252/nirp.bcn.9.2.121] [PMID] [PMCID]
  15. Oertel J, Gaab MR, Tschan CA, Linsler S. Mononostril endoscopic transsphenoidal approach to sellar and peri-sellar lesions: Personal experience and literature review. British Journal of Neurosurgery. 2015; 29(4):532-7. [DOI:10.3109/02688697.2015.1014997] [PMID]
  16. Bodhinayake I, Ottenhausen M, Mooney MA, Kesayabhotla K, Christos P, Schwarz JT, et al. Results and risk factors for recurrence following endoscopic endonasal transsphenoidal surgery for pituitary adenoma. Clinical Neurology and Neurosurgery. 2014; 119:75-9. [DOI:10.1016/j.clineuro.2014.01.020] [PMID]
  17. Han S, Ding X, Tie X, Liu Y, Xia J, Yan A, et al. Endoscopic endonasal trans-sphenoidal approach for pituitary adenomas: Is one nostril enough? Acta Neurochirurgica. 2013; 155(9):1601-9. [DOI:10.1007/s00701-013-1788-8] [PMID]
  18. Charalampaki P, Ayyad A, Kockro RA, Perneczky A. Surgical complications after endoscopic transsphenoidal pituitary surgery. Journal of Clinical Neuroscience. 2009; 16(6):786-9. [DOI:10.1016/j.jocn.2008.09.002] [PMID]
  19. Conrad J, Ayyad A, Wüster C, Omran W, Weber MM, Konerding MA, et al. Binostril versus mononostril approaches in endoscopic transsphenoidal pituitary surgery: Clinical evaluation and cadaver study. Journal of Neurosurgery. 2016; 125(2):334-45. [DOI:10.3171/2015.6.JNS142637] [PMID]
  20. Dallapiazza RF, Grober Y, Starke RM, Laws ER, Jane Jr JA. Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas. Neurosurgery. 2015; 76(1):42-52. [DOI:10.1227/NEU.0000000000000563] [PMID]
  21. Wang ZL, Zhang QH, Li MC, Yan B, Wei TT, Peng SY, et al. [The impact of resection of skull base tumor via an endoscopic endonasal approach on the visual function of vision impaired patients and the analysis of factors affecting their visual recovery (Chinese)]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery. 2018; 53(4):244-50. [DOI:0.3760/cma.j.issn.1673-0860.2018.04.002] [PMID]
  22. Goudakos JK, Markou KD, Georgalas C. Endoscopic versus microscopic trans-sphenoidal pituitary surgery: A systematic review and meta-analysis. Clinical Otolaryngology. 2011; 36(3):212-20. [DOI:10.1111/j.1749-4486.2011.02331.x] [PMID]
  23. Jho HD. Endoscopic transsphenoidal surgery. Journal of Neuro-oncology. 2001; 54(2):187-95. [DOI:10.1023/A:1012969719503] [PMID]
  24. Maric A, Kruljac I, Cerina V, Pecina HI, Sulentic P, Vrkljan M. Endocrinological outcomes of pure endoscopic transsphenoidal surgery: A croatian referral pituitary center experience. Croatian Medical Journal. 2012; 53(3):224-33. [DOI:10.3325/cmj.2012.53.224] [PMID] [PMCID]
  25. Gondim JA, Almeida JP, de Albuquerque LAF, Gomes E, Schops M, Ferraz T. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: Results of 67 cases treated in a pituitary center. Neurosurg Focus. 2010; 29(4):E7. [DOI:10.3171/2010.7.FOCUS10167] [PMID]
  26. Chi F, Wang Y, Lin Y, Ge J, Qiu Y, Guo L. A Learning curve of endoscopic transsphenoidal surgery for pituitary adenoma. Journal of Craniofacial Surgery. 2013; 24(6):2064-7. [DOI:10.1097/SCS.0b013e3182a24328] [PMID]
  27. Jane Jr JA, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, et al. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. Journal of Clinical Endocrinology & Metabolism. 2011; 96(9):2732-40. [DOI:10.1210/jc.2011-0554] [PMID]
  28. Samy Youssef A, Agazzi S, van Loveren HR. Transcranial surgery for pituitary adenomas. Neurosurgery. 2005; 57(Suppl 1):168-75. [DOI:10.1227/01.NEU.0000163602.05663.86] [PMID]
  29. Prajapati HP, Jain SK, Sinha VD. Endoscopic versus microscopic pituitary adenoma surgery: An institutional experience. Asian Journal of Neurosurgery. 2018; 13(2):217-21. [DOI:10.4103/ajns.AJNS_160_16] [PMID] [PMCID]
  30. Cappabianca P, Cavallo LM, Colao A, de Divitiis E. Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. Journal of Neurosurgery. 2002; 97(2):293-8. [DOI:10.3171/jns.2002.97.2.0293] [PMID]
  31. Colao A, Di Sarno A, Guerra E, Pivonello P, Cappabianca P, Caranci F, et al. Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. Clinical Endocrinology. 2007; 67(3):426-33. [DOI:10.1111/j.1365-2265.2007.02905.x] [PMID]
  32. Sol YL, Lee SK, Choi HS, Lee YH, Kim J, Ki SH. Evaluation of MRI criteria for cavernous sinus invasion in pituitary macroadenoma. Journal of Neuroimaging. 2014; 24(5):498-503. [DOI:10.1111/j.1552-6569.2012.00710.x] [PMID]
  33. Recinos PF, Goodwin CR, Berm H, Quiñones-Hinojosa A. Transcranial surgery for pituitary macroadenomas. In: Quinones-Hinojosa A, editor. Schmidek and Sweet: Operative Neurosurgical Techniques E-Book: Indications, Methods and Results (Expert Consult - Online and Print). Amsterdam: Elsevier Health Sciences: 2012. [DOI:10.1016/B978-1-4160-6839-6.10023-1]
  34. Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, et al. Treatment of acromegaly by endoscopic transsphenoidal surgery: Surgical experience in 214 cases and cure rates according to current consensus criteria. Journal of Neurosurgery. 2013; 119(6):1467-77. [DOI:10.3171/2013.8.JNS13224] [PMID]
  35. Gao Y, Zhong C, Wang Y, Xu S, Guo Y, Dai C, et al. Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: A meta-analysis. World Journal of Surgical Oncology. 2014; 12:94. [DOI:10.1186/1477-7819-12-94] [PMID] [PMCID]
  36. Kabil MS, Eby JB, Shahinian HK. Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg. 2005; 48(6):348-54. [DOI:10.1055/s-2005-915635] [PMID]
  37. El-Fiki ME, Aly A, Elwany S. Binasal endoscopic approach to the sellar region: Experience and outcome analysis of 80 cases. Journal of Neurological Surgery. Part B, Skull Base. 2012; 73(4):287-91. [DOI:10.1055/s-0032-1312714] [PMID] [PMCID]
  38. Cappabianca P, Cavallo LM, de Divitiis O, Solari D, Esposito F, Colao A. Endoscopic pituitary surgery. Pituitary. 2008; 11(4):385-90. [DOI:10.1007/s11102-008-0087-5] [PMID]
  39. Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF. The endonasal microscopic approach for pituitary adenomas and other parasellar tumors: A 10-year experience. Neurosurgery. 2008; 63(4 Suppl 2):244-56. [DOI:10.1227/01.NEU.0000327025.03975.BA] [PMID]
  40. Frank G, Pasquini E, Farneti G, Mazzatenta D, Sciarretta V, Grasso V, et al. The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology. 2006; 83(3-4):240-8. [DOI:10.1159/000095534] [PMID]
  41. Nakao N, Nakai K, Itakura T. A minimally invasive endoscopic transsphenoidal approach with an endonasal septal pushover technique by using a modified nasal speculum. Minimally Invasive Neurosurgery: MIN. 2006; 49(1):20-4.[DOI:10.1055/s-2005-919148] [PMID]
  42. Griffiths CF, Cutler AR, Duong HT, Bardo G, Karimi K, Barkhoudarian G, et al. Avoidance of postoperative epistaxis and anosmia in endonasal endoscopic skull base surgery: A technical note. Acta Neurochir. 2014; 156(7):1393-401. [DOI:10.1007/s00701-014-2107-8] [PMID]
  43. Rivera-Serrano CM, Snyderman CH, Gardner P, Prevedello D, Wheless S, Kassam AB, et al. Nasoseptal "rescue" flap: A novel modification of the nasoseptal flap technique for pituitary surgery. Laryngoscope. 2011; 121(5):990-3. [DOI:10.1002/lary.21419] [PMID]
Type of Study: Review | Subject: Neuroscience

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Neurosurgery

Designed & Developed by: Yektaweb